Century Therapeutics, Inc. (NASDAQ:IPSC) Receives Average Recommendation of “Buy” from Analysts
Shares of Century Therapeutics, Inc. (NASDAQ:IPSC – Get Free Report) have received a consensus recommendation of “Buy” from the six analysts that are currently covering the company, Marketbeat reports. Six equities research analysts have rated the stock with a buy recommendation. The average 12 month price target among brokerages that have issued a report on […]
Shares of Century Therapeutics, Inc. (NASDAQ:IPSC – Get Free Report) have received a consensus recommendation of “Buy” from the six analysts that are currently covering the company, Marketbeat reports. Six equities research analysts have rated the stock with a buy recommendation. The average 12 month price target among brokerages that have issued a report on […]
